Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries... Show more
Aemetis, Inc. is a diversified renewable natural gas and renewable fuels company operating across three distinct platforms: California dairy RNG, a 65-million-gallon-per-year ethanol plant in Keyes, California, and an 80-million-gallon-per-year biodiesel facility in India, alongside developing sustainable aviation fuel (SAF) and carbon sequestration projects. This geographic and product diversification reduces single-market dependence while exposing the company to multiple regulatory and demand cycles.
The structural advantage lies in California's low-carbon fuel policies. The state's Low Carbon Fuel Standard (LCFS) program, extended for 20 years, rewards very low carbon-intensity fuels with valuable credits. Aemetis's dairy RNG, produced from captured methane, qualifies for premium environmental attributes, including D3 RINs (Renewable Identification Numbers) and LCFS credits, creating a recurring revenue stream tied to policy rather than commodity pricing alone. As the company adds digesters and scales production, these credit revenues are expected to compound, supporting its medium-term market positioning.
However, the company carries structural constraints: negative shareholder equity, rising leverage, and negative operating cash flow. These factors limit balance-sheet flexibility and mean the growth narrative depends heavily on successful execution of capital projects and regulatory credit monetization.
Several developments could materially shape investor sentiment. The most concrete is the MVR (mechanical vapor recompression) system at the Keyes ethanol plant, which the company expects to cut natural gas consumption by roughly 80%, lower the ethanol's carbon intensity, and add approximately $32 million in annual cash flow upon completion in 2026. This is a self-funded efficiency lever independent of external demand.
Tax-credit monetization is a second catalyst. Aemetis completed its first sale of Section 45Z clean fuel production credits and expects additional transfers in 2026, plus an approved Section 45C credit worth about $10.5 million. Finalization of Department of Energy emissions-rate calculations and LCFS credit pricing trends could amplify these flows.
The India subsidiary's targeted 2026 IPO represents a potential strategic inflection point, offering a path to fund expansion in biogas and SAF while potentially crystallizing value for the parent. Analyst coverage reflects optimism but wide dispersion: consensus ratings lean toward Buy, with 12-month price targets ranging from roughly $2.50 to $28 and averages clustering around $13 to $14, underscoring how much depends on execution and policy clarity rather than near-term earnings.
Aemetis's trajectory is tightly linked to policy and commodity markets. Renewable fuel producers benefit when oil prices are elevated, as biofuel alternatives become more economically attractive, though credit-based revenues provide some insulation. Corn prices directly influence ethanol margins, while dairy RNG economics hinge on LCFS credit values, which have strengthened following the program's 20-year extension.
Interest rates and inflation matter through their effect on project financing costs. With limited cash and reliance on external capital, Aemetis is sensitive to credit conditions. Geopolitical energy dynamics also favor domestic and allied renewable fuel production, and India's government blending mandates support that subsidiary's demand outlook. Regulatory climate remains the defining macro variable: changes to federal tax-credit guidance, California E15 (15% ethanol) blending approvals, and India's biodiesel mandates can all shift the earnings power of the platform.
Tickeron's Trend Prediction Engine is an AI-powered forecasting tool that helps traders assess whether a stock, ETF (exchange-traded fund), or other asset may trend bullish, bearish, or sideways over the next week or month. It is designed to help users identify developing trends, evaluate potential breakouts or reversals, and explore predictions across a broad universe of tradable instruments. The product includes searchable prediction categories, historical context, and alert-oriented functionality to support timely decision-making. Investors tracking Aemetis and other names can use the engine to monitor evolving momentum signals alongside their own research.
Looking toward 2026 and beyond, several structural themes will define Aemetis's trajectory. The first is RNG scale-up: as additional digesters come online, the biogas segment's positive net income and EBITDA (earnings before interest, taxes, depreciation, and amortization) should expand, gradually shifting the earnings mix toward higher-margin credit-backed revenue. Consensus revenue forecasts point to substantial top-line growth in the coming years as this platform matures.
The second theme is cost-structure evolution. The MVR upgrade and tax-credit monetization are designed to move the business toward self-funded cash generation, a necessary condition for reducing dependence on refinancing and improving margin sustainability. The third is capital allocation and deleveraging: an India IPO and refinancing efforts could address the balance-sheet constraints that currently weigh on the stock.
Competitive threats include larger, better-capitalized renewable fuel producers and policy volatility, particularly around federal tax-credit guidance. The transition toward SAF and carbon sequestration represents a longer-dated optionality that could reshape the company's addressable market but requires substantial capital. Analysts' price targets remain widely dispersed, reflecting genuine uncertainty about whether execution and policy tailwinds converge. As with any development-stage clean energy name, the gap between strategic ambition and realized cash flow will be the central factor investors watch through 2026.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| QQLV | 27.22 | 0.14 | +0.53% |
| Invesco QQQ Low Volatility ETF (QQLV) | |||
| ITB | 94.01 | 0.24 | +0.26% |
| iShares U.S. Home Construction ETF (ITB) | |||
| NUHY | 20.28 | -0.03 | -0.15% |
| Nuveen ESG High Yield Corporate Bond ETF (NUHY) | |||
| SCD | 15.16 | -0.03 | -0.20% |
| LMP Capital and Income Fund | |||
| FMTL | 31.19 | -0.53 | -1.67% |
| First Trust Indxx Critical Metals ETF (FMTL) | |||
A.I.dvisor indicates that over the last year, AMTX has been loosely correlated with GEVO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if AMTX jumps, then GEVO could also see price increases.
| Ticker / NAME | Correlation To AMTX | 1D Price Change % | ||
|---|---|---|---|---|
| AMTX | 100% | -9.77% | ||
| GEVO - AMTX | 35% Loosely correlated | -1.61% | ||
| DINO - AMTX | 31% Poorly correlated | +0.03% | ||
| PARR - AMTX | 31% Poorly correlated | +1.49% | ||
| CLNE - AMTX | 31% Poorly correlated | -7.07% | ||
| WLK - AMTX | 30% Poorly correlated | +1.32% | ||
More | ||||
| Ticker / NAME | Correlation To AMTX | 1D Price Change % |
|---|---|---|
| AMTX | 100% | -9.77% |
| Process Industries category (164 stocks) | 11% Poorly correlated | -0.61% |
| Chemicals: Specialty category (61 stocks) | 7% Poorly correlated | -1.68% |
a producer of renewable chemicals and fuels using patented microbes and processes
Industry ChemicalsSpecialty
The RSI Oscillator for AMTX moved out of oversold territory on November 04, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 48 similar instances when the indicator left oversold territory. In 41 of the 48 cases the stock moved higher. This puts the odds of a move higher at 85%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Moving Average Convergence Divergence (MACD) for AMTX just turned positive on November 05, 2026. Looking at past instances where AMTX's MACD turned positive, the stock continued to rise in 28 of 38 cases over the following month. The odds of a continued upward trend are 74%.
Following a +50.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMTX advanced for three days, in 187 of 232 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Momentum Indicator moved below the 0 level on November 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AMTX as a result. In 68 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.
AMTX moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
AMTX broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AMTX entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 60 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 81 (best 1 - 100 worst), indicating slightly worse than average price growth. AMTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.363) is normal, around the industry mean (2.284). P/E Ratio (-1.884) is within average values for comparable stocks, (-17.137). AMTX's Projected Growth (PEG Ratio) (19.780) is very high in comparison to the industry average of (1.548). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (0.555) is also within normal values, averaging (48.960).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.